Clinical Trial Update: A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6

View source ↗

Summary

A pilot study evaluating varying doses of tamoxifen in breast cancer patients with respect to CYP2D6 genetic polymorphisms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Breast Cancer | Status: COMPLETED